Imperial College London

ProfessorPatrickSerruys

Faculty of MedicineNational Heart & Lung Institute

Visiting Professor
 
 
 
//

Contact

 

p.serruys

 
 
//

Location

 

c/o Prof Kim FoxGuy Scadding BuildingRoyal Brompton Campus

//

Summary

 

Publications

Publication Type
Year
to

926 results found

Piazza N, van Gameren M, Jueni P, Wenaweser P, Carrel T, Onuma Y, Gahl B, Hellige G, Otten A, Kappetein A-P, Takkenberg JJM, van Domburg R, de Jaegere P, Serruys PW, Windecker Set al., 2009, A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-centre study, EUROINTERVENTION, Vol: 5, Pages: 580-588, ISSN: 1774-024X

Journal article

Sarno G, Schultz C, Garg S, Ligthart J, Garcia HM, Serruys PWet al., 2009, How should I treat a complex Post-CABG patient?, EUROINTERVENTION, Vol: 5, Pages: 627-628, ISSN: 1774-024X

Journal article

Garg S, Serruys P, 2009, Biodegradable stents and non-biodegradable stents., Minerva Cardioangiol, Vol: 57, Pages: 537-565, ISSN: 0026-4725

The introduction of the coronary stent in 1986 was one of the most far-reaching changes in the practice of interventional cardiology since its inception in 1977. Despite all the benefits of the using a metallic drug eluting stent (DES), their limitations have generated interest towards biodegradable technology. These biodegradable stents, which are made of polymers or metal alloys with or without a drug coating, have the potential to scaffold the artery to allow natural healing to take place, and then biodegrade. The development of this technology has been slow, however several biodegradable stents have entered into clinical trials, with many more at the preclinical stage of development. Concurrently conventional metallic DES have tried to address their limitations; in particular they have sought to repair their damaged reputation following concerns over stent thrombosis. Accordingly, stents with a more biocompatible polymer and DES which are polymer-free have been developed, and are currently being evaluated in clinical trials. This article will review the status of biodegradable stents, and these newer DES, during this exciting period in interventional cardiology as technology strives to develop the ideal coronary stent.

Journal article

Wykrzykowska JJ, Raeber L, de Vries T, Bressers M, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M-C, di Mario C, Regar E, Juni P, Windecker S, Serruys PWet al., 2009, Biolimus-eluting Biodegradable Polymer Versus Sirolimus-eluting Permanent Polymer Stent Performance In Long Lesions. Results From The LEADERS Multicenter Trial Substudy, 21st Annual Transcatheter Cardiovascular Therapeutics Conference, Publisher: EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC, Pages: 135D-136D, ISSN: 0002-9149

Conference paper

Linke A, Lenk K, Serruys PW, van Es G-A, Buszman P, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M-C, di Mario C, Juni P, Schuler G, Windecker Set al., 2009, Impact of Diabetes on Angiographic And Clinical Outcomes of Revascularization With Biolimus-eluting Stent With Biodegradable Polymer and Sirolimus-eluting Stent With Durable Polymer. LEADERS Trial Substudy, 21st Annual Transcatheter Cardiovascular Therapeutics Conference, Publisher: EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC, Pages: 138D-138D, ISSN: 0002-9149

Conference paper

Yeo KK, Daemen J, Rogers JH, Serruys Pet al., 2009, The use of drug-eluting stents in ST-elevation myocardial infarction, EUROINTERVENTION, Vol: 5, Pages: 494-500, ISSN: 1774-024X

Journal article

Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Gonzalo N, Cook S, Marra S, Moretti C, De Servi S, Palacios IF, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys PWet al., 2009, Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT), INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 137, Pages: 16-21, ISSN: 0167-5273

Journal article

Wykrzykowska JJ, Serruys PW, Onuma Y, de Vries T, van Es G-A, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice M-C, di Mario C, van Geuns RJ, Juni P, Windecker Set al., 2009, Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization With Biolimus-Eluting Stent With Biodegradable Polymer and Sirolimus-Eluting Stent With Durable Polymer The LEADERS Trial Substudy, JACC-CARDIOVASCULAR INTERVENTIONS, Vol: 2, Pages: 861-870, ISSN: 1936-8798

Journal article

Vranckx P, Otten A, Schultz C, Van Domburg R, de Jaegere P, Serruys PWet al., 2009, Assisted circulation using the Tandemheart (R), percutaneous transseptal left ventricular assist device, during percutaneous aortic valve implantation: the Rotterdam experience, EUROINTERVENTION, Vol: 5, Pages: 465-469, ISSN: 1774-024X

Journal article

Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LSD, van Domburg RT, Serruys PWet al., 2009, Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials, EUROPEAN HEART JOURNAL, Vol: 30, Pages: 2102-2108, ISSN: 0195-668X

Journal article

Regar E, Dimario C, Macaya C, Termijn Y, Gobbens P, Commissaris K, Gonzalo N, Serruys PWet al., 2009, The incidence of incomplete stent strut apposition. Insights from the randomized, multicenter OCT Resolute III substudy, EUROPEAN HEART JOURNAL, Vol: 30, Pages: 242-242, ISSN: 0195-668X

Journal article

Schultz CJ, Weustink A, Piazza N, Otten A, Mollet N, Krestin G, van Geuns RJ, de Feyter P, Serruys PWJ, de Jaegere Pet al., 2009, Geometry and degree of apposition of the CoreValve ReValving system with multislice computed tomography after implantation in patients with aortic stenosis., J Am Coll Cardiol, Vol: 54, Pages: 911-918

OBJECTIVES: Using multislice computed tomography (MSCT), we sought to evaluate the geometry and apposition of the CoreValve ReValving System (CRS, Medtronic, Luxembourgh, Luxembourgh) in patients with aortic stenosis. BACKGROUND: There are no data on the durability of percutaneous aortic valve replacement. Geometric factors may affect durability. METHODS: Thirty patients had MSCT at a median 1.5 months (interquartile range [IQR] 0 to 7 months) after percutaneous aortic valve replacement. Axial dimensions and apposition of the CRS were evaluated at 4 levels: 1) the ventricular end; 2) the nadir; 3) central coaptation of the CRS leaflets; and 4) commissures. Orthogonal smallest and largest diameters and cross-sectional surface area were measured at each level. RESULTS: The CRS (26-mm: n = 14, 29-mm: n = 16) was implanted at 8.5 mm (IQR 5.2 to 11.0 mm) below the noncoronary sinus. None of the CRS frames reached nominal dimensions. The difference between measured and nominal cross-sectional surface area at the ventricular end was 1.6 cm(2) (IQR 0.9 to 2.6 cm(2)) and 0.5 cm(2) (IQR 0.2 to 0.7 cm(2)) at central coaptation. At the level of central coaptation the CRS was undersized relative to the native annulus by 24% (IQR 15% to 29%). The difference between the orthogonal smallest and largest diameters (degree of deformation) at the ventricular end was 4.4 mm (IQR 3.3 to 6.4 mm) and it decreased progressively toward the outflow. Incomplete apposition of the CRS frame was present in 62% of patients at the ventricular end and was ubiquitous at the central coaptation and higher. CONCLUSIONS: Dual-source MSCT demonstrated incomplete and nonuniform expansion of the CRS frame, but the functionally important mid-segment was well expanded and almost symmetrical. Undersizing and incomplete apposition were seen in the majority of patients.

Journal article

Pedersen SS, Denollet J, de Jonge P, Simsek C, Serruys PW, van Domburg RTet al., 2009, Brief Depression Screening with the PHQ-2 Associated with Prognosis Following Percutaneous Coronary Intervention with Paclitaxel-Eluting Stenting, JOURNAL OF GENERAL INTERNAL MEDICINE, Vol: 24, Pages: 1037-1042, ISSN: 0884-8734

Journal article

Garcia-Garcia HM, Gonzalo N, Regar E, Serruys PWet al., 2009, Virtual histology and optical coherence tomography: from research to a broad clinical application, HEART, Vol: 95, Pages: 1362-1374, ISSN: 1355-6037

Journal article

Garg S, Serruys P, 2009, Drug-Eluting Stents Are Safe, CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol: 86, Pages: 130-132, ISSN: 0009-9236

Journal article

Wykrzykowska JJ, Raeber L, de Vries T, Bressers M, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M-C, di Mario C, Regar E, Jueni P, Windecker S, Serruys PWet al., 2009, Biolimus-eluting biodegradable polymer versus sirolimuseluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy, EUROINTERVENTION, Vol: 5, Pages: 310-317, ISSN: 1774-024X

Journal article

Serruys PW, 2009, Our European present, EUROINTERVENTION, Vol: 5, Pages: 283-283, ISSN: 1774-024X

Journal article

Garcia-Garcia HM, Serruys PW, 2009, Phospholipase A(2) inhibitors, CURRENT OPINION IN LIPIDOLOGY, Vol: 20, Pages: 327-332, ISSN: 0957-9672

Journal article

Bruining N, de Winter S, Serruys PW, 2009, Intravascular Ultrasound Registration/Integration with Coronary Angiography, CARDIOLOGY CLINICS, Vol: 27, Pages: 531-+, ISSN: 0733-8651

Journal article

Vranckx P, Schultz CJ, Valgimigli M, Eindhoven JA, Kappetein AP, Regar ES, Van Domburg R, Serruys PWet al., 2009, Assisted Circulation Using the Tandemheart (R) During Very High-Risk PCI of the Unprotected Left Main Coronary Artery in Patients Declined for CABG, CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol: 74, Pages: 302-310, ISSN: 1522-1946

Journal article

Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G, van der Giessen W, Regar Eet al., 2009, Optical coherence tomography patterns of stent restenosis, AMERICAN HEART JOURNAL, Vol: 158, Pages: 284-293, ISSN: 0002-8703

Journal article

Claessen BE, Beijk MA, Legrand V, Ruzyllo W, Manari A, Varenne O, Suttorp MJ, Tijssen JGP, Miquel-Hebert K, Veldhof S, Henriques JPS, Serruys PW, Piek JJet al., 2009, Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions The SPIRIT II Trial, CIRCULATION-CARDIOVASCULAR INTERVENTIONS, Vol: 2, Pages: 339-347, ISSN: 1941-7640

Journal article

Onuma Y, Kukreja N, Piazza N, Eindhoven J, Girasis C, Schenkeveld L, van Domburg R, Serruys PWet al., 2009, The Everolimus-Eluting Stent in Real-World Patients 6-Month Follow-Up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) Registry, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol: 54, Pages: 269-276, ISSN: 0735-1097

Journal article

Simsek C, Pedersen SS, van Gestel YRBM, Erdman RAM, Daemen J, Serruys PW, van Domburg RTet al., 2009, Feelings of being disabled as a prognostic factor for mortality in the drug-eluting stent era, JOURNAL OF PSYCHOSOMATIC RESEARCH, Vol: 67, Pages: 85-91, ISSN: 0022-3999

Journal article

Serruys P, Garg S, 2009, Percutaneous Coronary Interventions for All Patients With Complex Coronary Artery Disease: Triple Vessel Disease or Left Main Coronary Artery Disease. Yes? No? Don't Know?, REVISTA ESPANOLA DE CARDIOLOGIA, Vol: 62, Pages: 719-725, ISSN: 0300-8932

Journal article

Kukreja N, Serruys PW, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Goedhart D, Macours N, Stoll HPet al., 2009, Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II), HEART, Vol: 95, Pages: 1061-1066, ISSN: 1355-6037

Journal article

Cheng C, Noordeloos AM, Jeney V, Soares MP, Moll F, Pasterkamp G, Serruys PW, Duckers HJet al., 2009, Heme Oxygenase 1 Determines Atherosclerotic Lesion Progression Into a Vulnerable Plaque, CIRCULATION, Vol: 119, Pages: 3017-A9, ISSN: 0009-7322

Journal article

Pedersen SS, Denollet J, Erdman RAM, Serruys PW, van Domburg RTet al., 2009, Co-occurrence of diabetes and hopelessness predicts adverse prognosis following percutaneous coronary intervention, JOURNAL OF BEHAVIORAL MEDICINE, Vol: 32, Pages: 294-301, ISSN: 0160-7715

Journal article

Chevalier B, Silber S, Park S-J, Garcia E, Schuler G, Suryapranata H, Koolen J, Hauptmann KE, Wijns W, Morice M-C, Carrie D, van Es G-A, Nagai H, Detiege D, Paunovic D, Serruys PWet al., 2009, Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberte Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries The NOBORI 1 Trial - Phase 2, CIRCULATION-CARDIOVASCULAR INTERVENTIONS, Vol: 2, Pages: 188-U57, ISSN: 1941-7640

Journal article

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.

Request URL: http://wlsprd.imperial.ac.uk:80/respub/WEB-INF/jsp/search-html.jsp Request URI: /respub/WEB-INF/jsp/search-html.jsp Query String: id=00712243&limit=30&person=true&page=26&respub-action=search.html